These were consistent with qPCR data showing that eif4ebp1 expression, a marker for reduced insulin signaling (Figueroa-Clarevega and Bilder, 2015; Kwon et al., 2015), was not affected by the intestinal tumor (Fig. 5H). Here, EIF4EBP1 is linked to intestinal neoplasm.